RSS

contract development and manufacturing organisation (CDMO)

Investment-type holding company of SK Group, SK Holdings, has come to an arrangement where it will acquire 100% of the ownership interests in AMPAC Fine Chemicals (AFC) — a contract development and manufacturing organisation (CDMO). more

News

Contract development and manufacturing organisation (CDMO), Juniper Pharma Services, has continued its strategic capital investment with the purchase of three additional pieces of processing equipment. more

Technology

Contract development and manufacturing organisation (CDMO), Juniper Pharma Services, has revealed its expansion into its UK-based drug development and clinical trial manufacturing facilities. more

News

Minakem, the contract development and manufacturing organisation (CDMO) division of Minafin, has revealed it is in the final qualification run to open a new closed-controlled environment high containment production facility in August. more

News

CDMO, Recipharm, has acquired Sanofi’s manufacturing centre and business located in Holmes Chapel, which will provide the company with a platform to take advantage of the growing respiratory drug market. more

News

Vetter, has launched its Open Innovation Challenge campaign, aimed at developing innovative, future-focused and sustainable solutions for the injection of medicines that are better streamlined to user needs than current methods. more

News

ADC Biotechnology has predicted that the next crucial phase of innovation to optimise and streamline production processes of antibody drug conjugates will be designed at the clinical development stage by specialist, ADC focused service providers more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has partnered with Hadasit Medical Research Services and Development to deliver combined clinical, biological and chemical services. more

News

Ardena, a contract development and manufacturing organisation (CDMO), has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients. more

News

Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, is investing £6 million in its pilot plant facility at its UK site for the enhancement of scale-up and small to midscale commercial API manufacturing capabilities. more

News

In this article, Maria Andrielou, marketing & communication, and Thanos Andreou, scientific affairs, at VIO Chemicals, give their views on how to get the best out of process R&D. more

, Opinion

Contract development and manufacturing organisation (CDMO), Recipharm, has been recognised in the CMO Leadership Awards for 2018, organised by Life Science Leader. more

News

Contract development and manufacturing organisation (CDMO), Vetter, has won this year’s (2018) ISPE Facility of the Year Award (FOYA) in the Facility of the Future category for its Center for Visual Inspection and Logistics. more

Technology

Contract development and manufacturing organisation (CDMO), Hovione, has reported its recent capacity expansion and further future plans to support growth in its sites base in Portugal, Ireland and New Jersey, USA. more

Technology

Ardena, contract development and manufacturing organisation (CDMO), has acquired a contract manufacturer of novel active pharmaceutical ingredients (APIs) and nanomedicines, ChemConnection. more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has revealed that the winner of its 2017 International Environmental Award is Karen Kidd more

News

Micro-Sphere, a Swiss-based CDMO, has successfully completed the Swissmedic inspection of its expanded facility, allowing for the renewal of its GMP approved status and increased manufacturing capacity more

News

Contract development and manufacturing organisation (CDMO), Hovione, has concluded the sale of all its share capital of iMAX Diagnostic Imaging Holding, marking the end of the company’s supply of iopamidol and iohexol APIs to the generics industry more

News

Contract development and manufacturing organisation (CDMO), Recipharm, has signed a licensing agreement with Canadian drug development company, Altus Formulation, to offer new drug delivery technologies for value added medicines. more

Technology

Global contract pharmaceutical development and manufacturing organisation (CDMO), Almac Group, has completed a £20 million investment in its cold chain management capabilities with the opening of a facility in Northern Ireland. more

News